CA
NZ
UK
AU
IND
US
Niagen Bioscience develops and markets nicotinamide riboside chloride, branded Niagen, in both food-grade and pharmaceutical-grade formulations, with Tru Niagen as its best-known consumer product. The company trades on theNasdaqunder the ticker NAGE following its rebranding from ChromaDex, a change investors should keep in mind …
Sionna is a clinical-stage biopharmaceutical company developing medicines for cystic fibrosis (CF), a genetic disease driven by defects in the CFTR protein. The company went public onNasdaqin February 2025 and has pursued a differentiated approach aimed at stabilizing the NBD1 region of CFTR, alongside …
CEL-SCI is a clinical-stage immunotherapy company whose lead asset, Multikine (leukocyte interleukin injection), is being developed for certain head and neck cancers. In 2026 the company advanced on several fronts. On July 13, 2026, it launched a global, roughly 212-patient confirmatory registration Phase 3 …
Artelo Biosciences (NASDAQ: ARTL) is a clinical-stage biopharmaceutical company built around the biology of lipids and the endocannabinoid system. Its portfolio spans oncology-supportive care, pain and metabolic health. In its second-quarter 2026 update, released in August, the company reiterated progress across three programs and …
iTonic Holdings Ltd (NASDAQ: ITOC) is a healthcare technology company focused on brachytherapy, a form of cancer treatment that places radioactive sources inside or next to a tumor. The company develops treatment-planning systems and related software used in radiotherapy, and it is headquartered in …
Pulmatrix, Inc (NASDAQ: PULM) is a clinical-stage biotechnology company historically known for its iSPERSE inhaled dry-powder platform. In recent quarters it has functioned largely as a small, cash-conserving Nasdaq-listed shell seeking a strategic combination.
CalciMedica, Inc (NASDAQ: CALC) is a clinical-stage biopharmaceutical company developing Auxora, an intravenous inhibitor of calcium release-activated calcium (CRAC) channels. Its primary focus is acute pancreatitis (AP), a serious inflammatory condition with no approved targeted therapy.
Bio Green Med Solution, Inc (NASDAQ: BGMS) is headquartered in Kuala Lumpur, Malaysia, and operates in the industrials sector. Its business centers on distributing, trading and installing protective and fire-safety materials and equipment, along with fire protection and prevention systems. Despite the "Med" in …
Rafarma Pharmaceuticals describes itself as a multi-product pharmaceutical company focused onManufacturingand selling generic antibiotics, specialty medicines and anti-cancer drugs, with operations oriented toward Russian and international markets. The company is incorporated in Wyoming and its shares trade on the OTC Markets rather than a …
Beyond Air is a commercial-stage company built around its LungFit platform, which generates nitric oxide from ambient air. Its lead product, LungFit PH, is cleared to treat term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension. Over recent quarters the company …
Please wait processing your request...